Shortened telomeres: a driving force behind leukemia?

ISSN： 1479-6694

Source： Future Oncology, Vol.6, Iss.11, 2010-11, pp. : 1681-1686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Left behind: should minimal residual disease be treated in hairy cell leukemia?

By Park Jae H. Tallman Martin S.

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 971-972

Informa Healthcare

Access to resources Recommend Favorite

Unusual DNA Conformations: Implications for Telomeres

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 2, Iss. 5, 2002-09 ,pp. : 627-644

Bentham Science Publishers

Access to resources Recommend Favorite

Behind EUD

By Wang Jian Z. Mayr Nina A. Yuh William T. C.

Acta Oncologica, Vol. 47, Iss. 5, 2008-09 ,pp. : 971-972

Informa Healthcare

Access to resources Recommend Favorite

Bif-1 is overexpressed in hepatocellular carcinoma and correlates with shortened patient survival

By Fan Rengen Miao Yufeng Shan Xiangxiang Qian Haixin Song Changzhi Wu Guangzhou Chen Yan Zha Wenzhang

Oncology Letters, Vol. 3, Iss. 4, 2012-04 ,pp. : 851-854

Spandidos Publications

Access to resources Recommend Favorite

In response to 'Behind EUD'

By Mavroidis Panayiotis Lind Bengt

Acta Oncologica, Vol. 48, Iss. 4, 2009-05 ,pp. : 610-614

Informa Healthcare

Access to resources Recommend Favorite